Profile data is unavailable for this security.
About the company
Therapeutic Solutions International, Inc. is focused on immune modulation for the treatment of several specific diseases. The Company is developing a range of immune-modulatory agents to target certain cancers, schizophrenia, suicidal ideation, and traumatic brain injury (TBI), and for daily health. Its flagship product, QuadraMune, is a multi-patented synergistic blend of pterostilbene, sulforaphane, epigallocatechin gallate, and thymoquinone. Its synergistic blend of ingredients helps the immune system fight off common and complex ailments and promotes healthy T Cell activity. It has developed an allogenic version of StemVacs and has filed patents to cover activating universal donor immune system cells called dendritic cells in a manner so that upon injection they reprogram the body's natural killer (NK) cells. It has obtained exclusive rights to a patented adult stem cell for development of therapeutics in the area of chronic traumatic encephalopathy (CTE), TBI, and lung pathology.
- Revenue in USD (TTM)97.68k
- Net income in USD-2.18m
- Incorporated2007
- Employees3.00
- LocationTherapeutic Solutions International Inc701 Wild Rose LaneELK CITY 83525United StatesUSA
- Phone+1 (760) 295-7208
- Websitehttps://therapeuticsolutionsint.com/
Peer analysis
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Avinger Inc | 7.62m | -16.13m | 2.41m | 68.00 | -- | -- | -- | 0.3165 | -18.16 | -18.16 | 7.49 | -2.56 | 0.4084 | 1.20 | 6.38 | 112,102.90 | -102.83 | -70.93 | -- | -131.57 | 22.43 | 30.87 | -251.78 | -208.91 | 0.4764 | -10.02 | 1.38 | -- | -7.51 | -0.6736 | 32.76 | -- | -24.21 | -- |
Bioelectronics Corp | 1.61m | -289.82k | 2.47m | 9.00 | -- | -- | -- | 1.53 | -0.00002 | -0.00002 | 0.00007 | -0.0006 | 6.32 | 9.20 | 14.53 | -- | -113.86 | -383.59 | -- | -- | 49.43 | 51.48 | -18.01 | -143.48 | 0.0099 | -0.4909 | -- | -- | 94.01 | -5.09 | 75.01 | -- | -- | -- |
Nuwellis Inc | 8.90m | -19.93m | 2.69m | 59.00 | -- | 18.44 | -- | 0.3025 | -8.30 | -8.30 | 2.73 | 0.1304 | 0.7076 | 1.55 | 7.04 | 150,762.70 | -143.62 | -98.07 | -216.07 | -122.48 | 57.41 | 55.22 | -202.97 | -230.51 | 0.7092 | -4.75 | 0.00 | -- | 3.76 | 12.14 | -55.78 | -- | 4.61 | -- |
Kelyniam Global Inc | 517.70k | -420.28k | 2.79m | 0.00 | -- | 5.20 | -- | 5.38 | -0.0253 | -0.0253 | 0.0312 | 0.0179 | 0.4135 | 7.04 | 4.38 | -- | -33.57 | -- | -41.79 | -- | 18.86 | -- | -81.18 | -- | 1.26 | -- | 0.6232 | -- | -26.47 | -- | -19.10 | -- | -- | -- |
Tivic Health Systems Inc | 1.13m | -7.61m | 2.79m | 9.00 | -- | 0.3094 | -- | 2.46 | -11.17 | -11.17 | 1.02 | 1.46 | 0.2184 | 0.9237 | 17.31 | 126,000.00 | -146.51 | -- | -194.55 | -- | 30.07 | -- | -670.99 | -- | 2.07 | -- | 0.00 | -- | -36.09 | -- | 18.34 | -- | -- | -- |
BIOLASE Inc | 48.83m | -38.26m | 2.85m | 157.00 | -- | -- | -- | 0.0584 | -20.50 | -20.50 | 8.64 | 0.0081 | 1.28 | 2.21 | 9.00 | 311,006.40 | -55.75 | -49.28 | -118.58 | -85.80 | 34.25 | 35.27 | -43.56 | -50.72 | 0.6409 | -5.98 | 0.9812 | -- | 1.45 | 1.27 | -30.39 | -- | 18.63 | -- |
Vycor Medical Inc | 1.44m | -425.52k | 2.87m | 8.00 | -- | -- | -- | 2.00 | -0.0133 | -0.0135 | 0.0425 | -0.1078 | 1.59 | 0.6672 | 6.81 | 179,572.50 | -11.22 | -47.86 | -- | -- | 89.48 | 89.60 | -7.04 | -35.42 | 0.0861 | -0.0247 | -- | -- | 19.43 | -0.6542 | 46.49 | -- | -31.77 | -- |
Heart Test Laboratories Inc | 18.60k | -6.39m | 3.00m | 12.00 | -- | 33.75 | -- | 161.44 | -0.4912 | -0.4912 | 0.0009 | 0.1357 | 0.0026 | 0.009 | 2.53 | 1,550.00 | -89.51 | -- | -120.71 | -- | 67.31 | -- | -34,362.42 | -- | 4.70 | -16.41 | 0.0547 | -- | -64.16 | -- | -31.61 | -- | -- | -- |
Invo Bioscience Inc | 4.25m | -7.08m | 3.12m | 25.00 | -- | -- | -- | 0.7351 | -5.68 | -5.68 | 2.59 | 0.0039 | 0.3473 | 9.50 | 30.72 | 169,953.20 | -57.87 | -94.63 | -128.00 | -151.45 | 39.90 | 74.91 | -166.64 | -343.11 | 0.1629 | -5.86 | 0.9965 | -- | 267.38 | 43.62 | 26.24 | -- | 87.09 | -- |
Therapeutic Solutions International Inc | 97.68k | -2.18m | 3.21m | 3.00 | -- | 2.10 | -- | 32.90 | -0.0006 | -0.0006 | 0.00003 | 0.0003 | 0.0257 | 1.30 | 5.44 | 32,560.00 | -63.47 | -162.32 | -172.17 | -- | 63.36 | 67.79 | -2,468.37 | -2,391.85 | 0.4652 | -6.42 | 0.2868 | -- | -52.13 | 95.35 | 43.11 | -- | -- | -- |
Fuse Medical Inc | 18.40m | 3.63m | 3.33m | 31.00 | 1.25 | -- | 0.9016 | 0.1807 | 0.036 | 0.036 | 0.2307 | -0.0031 | 0.9593 | 0.7018 | 5.75 | 593,671.90 | 18.91 | 0.7504 | 48.45 | 1.35 | 64.95 | 54.98 | 19.72 | 0.6552 | 0.3143 | -1.13 | 1.12 | -- | -8.67 | -6.72 | 295.11 | 34.66 | -- | -- |
Applied DNA Sciences Inc | 5.52m | -12.50m | 3.70m | 53.00 | -- | -- | -- | 0.6698 | -17.13 | -17.13 | 7.67 | -0.0558 | 0.3893 | 10.38 | 4.64 | 104,110.80 | -87.15 | -88.57 | -111.09 | -121.91 | 33.98 | 44.35 | -223.89 | -113.26 | 1.54 | -- | -- | -- | -26.43 | 27.92 | -18.73 | -- | 33.80 | -- |
AccuStem Sciences Inc | 0.00 | -1.74m | 3.90m | 3.00 | -- | -- | -- | -- | -0.1537 | -0.1537 | 0.00 | -0.2309 | 0.00 | -- | -- | 0.00 | -1,168.46 | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | 45.26 | -- | -- | -- |
SINTX Technologies Inc | 2.78m | -8.88m | 3.94m | 43.00 | -- | 0.0138 | -- | 1.42 | -389.94 | -389.94 | 74.21 | 383.24 | 0.138 | 1.62 | 5.84 | 64,534.88 | -44.03 | -45.71 | -57.11 | -57.36 | 67.96 | 58.47 | -318.99 | -681.80 | 1.67 | -- | 0.0229 | -- | 68.29 | 94.24 | 49.75 | -- | 54.10 | -- |
Arch Therapeutics Inc | 130.55k | -8.43m | 4.00m | 8.00 | -- | -- | -- | 30.64 | -3.68 | -3.68 | 0.0425 | -2.45 | 0.0833 | 0.0637 | -- | 16,318.75 | -538.25 | -188.28 | -- | -804.63 | 33.37 | -- | -6,458.14 | -26,945.92 | 0.0164 | -1.27 | -- | -- | 383.83 | -- | -32.35 | -- | -21.76 | -- |
Holder | Shares | % Held |
---|---|---|
Strategic Investment Solutions, Inc. (Illinois)as of 31 Dec 2023 | 3.00k | 0.00% |